About Enzymotec
Enzymotec is a company based in Kfar Saba (Israel) founded in 1998 was acquired by Frutarom in October 2017.. Enzymotec has raised $21 million across 3 funding rounds from investors including Frutarom, TPY Capital and Ofer-Hi Tech. Enzymotec has completed 1 acquisition, including Union Springs Healthcare. Enzymotec operates in a competitive market with competitors including Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees, among others.
- Headquarter Kfar Saba, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Enzymotec
Enzymotec has successfully raised a total of $21M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $12.9 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $12.9M
-
First Round
First Round
(03 Feb 2009)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2017 | Amount | Post-IPO - Enzymotec | Valuation |
investors |
|
| Jan, 2012 | Amount | Series B - Enzymotec | Valuation | TPY Capital |
|
| Feb, 2009 | Amount | Series B - Enzymotec | Valuation | Ofer-Hi Tech , Millennium Materials Technologies Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enzymotec
Enzymotec has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Frutarom, TPY Capital and Ofer-Hi Tech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Traditional company manufacturing flavor and fine ingredients
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enzymotec
Enzymotec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Union Springs Healthcare. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Natural, therapeutically-validated products are developed for mainstream medicine.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Enzymotec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enzymotec Comparisons
Competitors of Enzymotec
Enzymotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Enzyme Technologies, The DuPont Nutrition and Health, Zivo Bioscience, Kaffe Bueno and Zarbees, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Enzymes are manufactured for nutrition, food, feed, and textile industries.
|
|
| domain | founded_year | HQ Location |
Manufactures a range of health ingredients
|
|
| domain | founded_year | HQ Location |
Bioactive compounds from algal strain
|
|
| domain | founded_year | HQ Location |
Coffee beans are supplied by Kaffe Bueno in multiple categories.
|
|
| domain | founded_year | HQ Location |
Natural cough remedies and wellness products are developed by Zarbees.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enzymotec
Frequently Asked Questions about Enzymotec
When was Enzymotec founded?
Enzymotec was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Where is Enzymotec located?
Enzymotec is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
Is Enzymotec a funded company?
Enzymotec is a funded company, having raised a total of $21M across 3 funding rounds to date. The company's 1st funding round was a Series B of $11M, raised on Feb 03, 2009.
What does Enzymotec do?
Enzymotec develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors. It develops, manufactures and markets bio-functional lipid ingredients, as well as final products, based on proprietary processes and technologies. Offerings encompass two segments - Nutrition ingredients for infant formulas and dietary supplements (sold through Advanced Lipids, our joint venture with AAK) and branded lipid-based medical foods for the dietary management of medical disorders and phospholipid-based bioactive ingredients for nutritional supplements. Other nutritional ingredients include krill oil and dietary supplements targeted at improving brain health providing benefits in memory, learning abilities and concentration. Enzymotec subsidiary Vaya Pharma manufactures lipid-based products for addressing dietary issues in Attention Deficit Hyperactivity Disorder (ADHD) and Hypertriglyceridemia.
Who are the top competitors of Enzymotec?
Enzymotec's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and The DuPont Nutrition and Health.
How many acquisitions has Enzymotec made?
Enzymotec has made 1 acquisition, including Union Springs Healthcare.
Who are Enzymotec's investors?
Enzymotec has 6 investors. Key investors include Frutarom, TPY Capital, Ofer-Hi Tech, Millennium Materials Technologies Fund, and Arancia.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.